8-K
filed November 26, 2025, 6:59 PM ET
ticker NRXP
CIK 0001719406
other material
confidence high
sentiment neutral
materiality 0.50
NRx Pharmaceuticals replaces auditor Salberg & Company with Weinberg & Company
NRX Pharmaceuticals, Inc.
- Engaged Weinberg & Company as independent auditor for FY ending Dec 31, 2025, effective Nov 20, 2025.
- Dismissed Salberg & Company on Nov 24, 2025; no disagreements or reportable events in prior years.
- Salberg's prior audit opinions contained a going-concern explanatory paragraph but were otherwise unqualified.
- Weinberg had previously audited Dura Medical LLC, a subsidiary acquired by Hope Therapeutics.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001437749-25-036452
- form_type
- 8-K
- ticker
- NRXP
- cik
- 0001719406
- company_name
- NRX Pharmaceuticals, Inc.
- filed_at
- 2025-11-26T23:59:59+00:00
- discovered_at
- 2026-05-14T18:02:40.247555+00:00
- generated_at
- 2026-05-16T16:32:17.150967+00:00
- sec_items
- ["4.01", "9.01"]
- event_type
- other_material
- sentiment
- neutral
- materiality_score
- 0.5
- calibrated_materiality_score
- 0.5
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001437749-25-036452
- json_url
- https://secwatch.observer/filing/0001437749-25-036452.json
- markdown_url
- https://secwatch.observer/filing/0001437749-25-036452.md
- text_url
- https://secwatch.observer/filing/0001437749-25-036452.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1719406/000143774925036452/0001437749-25-036452-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1719406/000143774925036452/nrxp20251125_8k.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
MXL
MaxLinear dismisses Grant Thornton, appoints KPMG as auditor for FY2026
MAXLINEAR, INC
June 1, 2026, 4:35 PM ET
other_material
Items 4.01, 9.01
same fact type: auditor_change
same SEC item: 4.01, 9.01
same event type: other_material
similar materiality
This filing
Engagement of New Independent Registered Public Accounting Firm and Dismissal of Independent Registered Public Accounting Firm On November 20, 2025, the audit committee of the board of directors (the “Audit Committee”) of NRx Pharmaceuticals, Inc. (the “Corporation”) approved the engagement of Weinberg & Company P.A. (“Weinberg”) as the Corporation’s independent registered public accounting firm for the fiscal year ending December 31, 2025. Weinberg had been previously engaged to audit the financial statements of Dura Medical LLC, which had been acquired by Hope Therapeutics, Inc.
Comparable filing
On May 28, 2026 (the “Effective Date”), MaxLinear, Inc. (the “Company”) dismissed Grant Thornton LLP (“Grant Thornton”) as the Company’s independent registered public accounting firm, effective immediately.
Filing page
SEC filing
OXSQ
Oxford Square Capital dismisses PwC, engages EY as independent auditor
Oxford Square Capital Corp.
May 29, 2026, 4:31 PM ET
other_material
Items 4.01, 9.01
same fact type: auditor_change
same SEC item: 4.01, 9.01
same event type: other_material
similar materiality
This filing
Engagement of New Independent Registered Public Accounting Firm and Dismissal of Independent Registered Public Accounting Firm On November 20, 2025, the audit committee of the board of directors (the “Audit Committee”) of NRx Pharmaceuticals, Inc. (the “Corporation”) approved the engagement of Weinberg & Company P.A. (“Weinberg”) as the Corporation’s independent registered public accounting firm for the fiscal year ending December 31, 2025. Weinberg had been previously engaged to audit the financial statements of Dura Medical LLC, which had been acquired by Hope Therapeutics, Inc.
Comparable filing
On May 26, 2026, Oxford Square Capital Corp. (the “Company”) dismissed PricewaterhouseCoopers LLP (“PwC”) as its independent registered public accounting firm and engaged Ernst & Young LLP (“EY”) as its new independent registered public accounting firm.
Filing page
SEC filing
SVCO
Silvaco dismisses Baker Tilly, appoints KPMG as independent auditor
Silvaco Group, Inc.
May 27, 2026, 5:25 PM ET
other_material
Items 4.01, 9.01
same fact type: auditor_change
same SEC item: 4.01, 9.01
same event type: other_material
similar materiality
This filing
Engagement of New Independent Registered Public Accounting Firm and Dismissal of Independent Registered Public Accounting Firm On November 20, 2025, the audit committee of the board of directors (the “Audit Committee”) of NRx Pharmaceuticals, Inc. (the “Corporation”) approved the engagement of Weinberg & Company P.A. (“Weinberg”) as the Corporation’s independent registered public accounting firm for the fiscal year ending December 31, 2025. Weinberg had been previously engaged to audit the financial statements of Dura Medical LLC, which had been acquired by Hope Therapeutics, Inc.
Comparable filing
on May 27, 2026, KPMG LLP (“KPMG”) was engaged as the Company’s independent registered public accounting firm
Filing page
SEC filing
AEYE
AudioEye dismisses MaloneBailey, appoints RSM as new auditor
AUDIOEYE INC
May 26, 2026, 4:18 PM ET
other_material
Items 4.01, 9.01
same fact type: auditor_change
same SEC item: 4.01, 9.01
same event type: other_material
similar materiality
This filing
Engagement of New Independent Registered Public Accounting Firm and Dismissal of Independent Registered Public Accounting Firm On November 20, 2025, the audit committee of the board of directors (the “Audit Committee”) of NRx Pharmaceuticals, Inc. (the “Corporation”) approved the engagement of Weinberg & Company P.A. (“Weinberg”) as the Corporation’s independent registered public accounting firm for the fiscal year ending December 31, 2025. Weinberg had been previously engaged to audit the financial statements of Dura Medical LLC, which had been acquired by Hope Therapeutics, Inc.
Comparable filing
On May 26, 2026, the Audit Committee of the Board of Directors of AudioEye, Inc. (the “Company”) approved the dismissal of MaloneBailey, LLP (“MaloneBailey”), which had been serving as the Company’s independent registered public accounting firm, effective immediately.
Filing page
SEC filing
WAST
Waste Energy Corp. replaces independent auditor; Integrität resigns, M&K CPAs appointed
WASTE ENERGY CORP.
May 22, 2026, 4:24 PM ET
other_material
Items 4.01, 9.01
same fact type: auditor_change
same SEC item: 4.01, 9.01
same event type: other_material
similar materiality
This filing
Engagement of New Independent Registered Public Accounting Firm and Dismissal of Independent Registered Public Accounting Firm On November 20, 2025, the audit committee of the board of directors (the “Audit Committee”) of NRx Pharmaceuticals, Inc. (the “Corporation”) approved the engagement of Weinberg & Company P.A. (“Weinberg”) as the Corporation’s independent registered public accounting firm for the fiscal year ending December 31, 2025. Weinberg had been previously engaged to audit the financial statements of Dura Medical LLC, which had been acquired by Hope Therapeutics, Inc.
Comparable filing
On May 21, 2026, the Audit Committee and Board of Directors approved the engagement of M&K CPAs, PLLC as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2025, subject to completion of customary client acceptance procedures and execution of a final engagement letter.
Filing page
SEC filing
SSGC
SafeSpace Global's auditor Rodefer Moss resigns; CBIZ CPAs appointed May 15
SafeSpace Global Corp
May 18, 2026, 4:47 PM ET
other_material
Items 4.01, 9.01
same fact type: auditor_change
same SEC item: 4.01, 9.01
same event type: other_material
similar materiality
This filing
Engagement of New Independent Registered Public Accounting Firm and Dismissal of Independent Registered Public Accounting Firm On November 20, 2025, the audit committee of the board of directors (the “Audit Committee”) of NRx Pharmaceuticals, Inc. (the “Corporation”) approved the engagement of Weinberg & Company P.A. (“Weinberg”) as the Corporation’s independent registered public accounting firm for the fiscal year ending December 31, 2025. Weinberg had been previously engaged to audit the financial statements of Dura Medical LLC, which had been acquired by Hope Therapeutics, Inc.
Comparable filing
On May 15, 2026, Rodefer Moss & Company, PLCC (“Rodefer Moss”) informed SafeSpace Global Corporation (the “Company”) that it is resigning as the Company’s independent registered public accounting firm.
Filing page
SEC filing
DFH
Dream Finders Homes dismisses PwC, appoints KPMG as auditor for FY 2026
Dream Finders Homes, Inc.
May 15, 2026, 5:20 PM ET
other_material
Items 4.01, 9.01
same fact type: auditor_change
same SEC item: 4.01, 9.01
same event type: other_material
similar materiality
This filing
Engagement of New Independent Registered Public Accounting Firm and Dismissal of Independent Registered Public Accounting Firm On November 20, 2025, the audit committee of the board of directors (the “Audit Committee”) of NRx Pharmaceuticals, Inc. (the “Corporation”) approved the engagement of Weinberg & Company P.A. (“Weinberg”) as the Corporation’s independent registered public accounting firm for the fiscal year ending December 31, 2025. Weinberg had been previously engaged to audit the financial statements of Dura Medical LLC, which had been acquired by Hope Therapeutics, Inc.
Comparable filing
the Audit Committee dismissed PwC as the Company’s independent registered public accounting firm.
Filing page
SEC filing
TUSK
Mammoth Energy Services replaces auditor Deloitte with Carr, Riggs & Ingram
MAMMOTH ENERGY SERVICES, INC.
May 15, 2026, 8:29 AM ET
other_material
Items 4.01, 9.01
same fact type: auditor_change
same SEC item: 4.01, 9.01
same event type: other_material
similar materiality
This filing
Engagement of New Independent Registered Public Accounting Firm and Dismissal of Independent Registered Public Accounting Firm On November 20, 2025, the audit committee of the board of directors (the “Audit Committee”) of NRx Pharmaceuticals, Inc. (the “Corporation”) approved the engagement of Weinberg & Company P.A. (“Weinberg”) as the Corporation’s independent registered public accounting firm for the fiscal year ending December 31, 2025. Weinberg had been previously engaged to audit the financial statements of Dura Medical LLC, which had been acquired by Hope Therapeutics, Inc.
Comparable filing
Also on May 13, 2026, the Audit Committee approved the engagement of Carr, Riggs & Ingram, L.L.C. (“CRI”) as its new independent registered public accounting firm.
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.